IL-4 in lymphoma: does the target matter?
Lossos
Izidore S
IS
Division of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, FL 33136, USA. ilossos@med.miami.edu
D006801:Humans; D015847:Interleukin-4 / Q000494:pharmacology / Q000627:therapeutic use*; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D015398:Signal Transduction / Q000187:drug effects; D016896:Treatment Outcome
D015847:Interleukin-4